Avesthagen Middle East FZ LLC

Avesthagen is a leading life science company pioneering the convergence between Food, Pharma and Population Genetics leading to Predictive Preventive Personalized Healthcare.



The business model of Avesthagen is to combine IP & product development through in-house research and collaborations. Avesthagen has built and continues to build an integrated, systems biology approach of capabilities, products, infrastructure and technology that allows for and facilitates ‘cross talk’ between numerous disciplines, leading to unique and innovative solutions. We employ 450 people worldwide and are headquartered in Bangalore, India.



Systems Biology Model. When it comes to discovery and scientific breakthrough we believe in putting together rather than taking apart, integration rather than reduction.

The pluralism of causes and effects in biological networks is better addressed by observing, through quantitative measures, multiple components simultaneously and by rigorous data integration and analysis. Systems biology is about looking at one event from different angles; it is about merging sciences at micro and macro levels. It means changing traditional scientific philosophy, in the full sense of the term.



Predictive Preventive Personalized Healthcare. We believe that healthcare will be revolutionized by genomic and stem cell research, becoming predictive, preventive, and personalized. The goal of personalized medicine is, first of all, to use the advanced tools of molecular genetics to predict how patients will respond to drugs, reducing harm and increasing benefit. The dual combination of diagnostic and treatment technologies is at the heart of personalized medicine and will transform healthcare dramatically. We have just entered the world of molecular medicine, and the realities of regenerative medicine and preventative healthcare are within our grasp.